Trial Profile
The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Prucalopride (Primary)
- Indications Dyspepsia; Gastrointestinal motility disorders
- Focus Therapeutic Use
- 22 Oct 2014 According to results published in 22nd United European Gastroenterology Week, status changed from recruiting to completed.
- 22 Oct 2014 Results presented at the 22nd United European Gastroenterology Week.
- 23 Sep 2014 New trial record